Entasis
is a biotechnology company that develops and commercializes antibiotic therapies for the treatment of bacterial infections... Read moreEntasis
is a biotechnology company that develops and commercializes antibiotic therapies for the treatment of bacterial infections... Read more
2015
2836 NAICS listing
News
May 25, 2023
Pharmabiz
Entasis: US FDA approves Entasis Therapeutics' Xacduro for treatment for pneumonia caused by certain difficulttotreat bacteria
Oct 19, 2022
GlobeNewswire
Press Release: Entasis : Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Presents Efficacy and Safety Data from Landmark Phase 3 ATTACK Trial at IDWEEK 2022
Jul 12, 2022
Citybizlist
Entasis: Innoviva Acquires Entasis Therapeutics
Jul 11, 2022
MarketScreener
Entasis: Entasis Therapeutics : Termination of a Material Definitive Agreement - Form 8-K
Jul 11, 2022
MarketScreener
Entasis: Innoviva Completes Acquisition of Entasis Therapeutics
Jun 22, 2022
NewsFile
Press Release: Entasis : The M&A Class Action Firm Continues to Investigate Entasis Therapeutics Holdings Inc. - ETTX
Jun 16, 2022
Global Legal Chronicle
Entasis: Innoviva's Acquisition of Entasis Therapeutics
Jun 09, 2022
FirstWord Pharma
Entasis: Entasis Therapeutics Presents Data on Sulbactam-Durlobactam and ETX0462 at 2022 ASM Microbe Annual Conference
May 25, 2022
The Business Journals
Entasis: AstraZeneca spinout, based in Waltham, acquired at 60% premium
May 24, 2022
MarketScreener
Entasis: Shareholder Alert: Ademi LLP investigates whether Entasis Therapeutics Holdings Inc. has obtained a Fair Price in its transaction with Innoviva
Entasis Competitors
1
2
3
4
5
6
7
8
9
10